San Diego, CA, United States of America

Wolfgang Scholz

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1993-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Wolfgang Scholz

Introduction

Wolfgang Scholz is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of nine patents to his name, Scholz's work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

One of Wolfgang Scholz's latest patents focuses on human monoclonal antibodies to ganglioside GD2. This invention provides compositions for the production of an antibody or functional fragment directed against disialoganglioside-GD2. The compositions include polynucleotides encoding a heavy chain and/or a light chain variable domain that binds to GD2. The invention also encompasses an isolated antibody or functional fragment and methods for treating or preventing diseases such as cancer or tumor formation. Furthermore, it provides a conjugate of an antibody or functional fragment fused to a diagnostic agent, detectable agent, or therapeutic agent, along with methods for treating, preventing, or diagnosing diseases in subjects in need.

Career Highlights

Throughout his career, Wolfgang Scholz has worked with notable companies, including Tanabe Seiyaku Company, Limited and Emergent Product Development Gaithersburg Inc. His experience in these organizations has contributed to his expertise in the field of antibody development and therapeutic applications.

Collaborations

Wolfgang Scholz has collaborated with several professionals in his field, including Ritsuko Sawada and Thomas J Lobl. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Wolfgang Scholz is a distinguished inventor whose work in human monoclonal antibodies has the potential to revolutionize treatments for serious diseases. His contributions to biotechnology and collaborations with other professionals highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…